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Dorin et al [Ref] ask several questions concerning the modeling of cortisol dynamics in our 
manuscript(1) and specifically, the potential consequences that Cortisol Binding Globulin (CBG) 
could have had on the estimates of the cortisol secretion rate and its modulation via ACTH.  The 
responses to these questions require their formulation in the following broader context. 
       One can formulate models of the cortisol dynamics and the travel of bound / unbound 
molecules in the blood circulation, at three levels.  At the finest level, cortisol molecules rapidly 
bind and unbind to CBG and albumin. The next level involves the rapid mixing, advection 
(movement with the inherent blood flow), and diffusion of the molecules within the blood.  
Blood cycles through the circulation at, roughly, 5L/min, and hence for a 70kg individual, once 
per minute.  After cortisol release, and 1-2 cycles through the heart, the molecules are 
reasonably well mixed. The other rapid effects, advection and diffusion, generally act on a 
similar time scale, with fast half-lives for most molecules being in the 2-4 min range.  The third 
level, the coarser scale of irrecoverable elimination, at which molecules exit the blood, the half-
lives are generally longer.  For cortisol, general population estimates are in the 45-70 min 
range.   
      In our manuscript(1), the model of cortisol dynamics in the blood was of two components:  
 
1. A fast rate of elimination that represented the entirety of mixing, advection and diffusion. 
2. A slow rate of (irrecoverable) elimination.   
 
The finest level of dynamics, the on- and off-binding to carrier proteins, was not included.  The 
basic model for (1)-(2) involves two coupled differential equations, in which a population-based 
fraction of allocation between the two was applied.  Under an assumption that the starting 
concentration is allocated by the same fraction, the evolving concentration can be written as a 
convolution with a biexponential decay rate.  In reply to the first question, the estimation of the 
kinetics and secretion was, as we would describe it, via a two-component model, which can be 
represented as bi-exponential convolution.   
     As mentioned by the authors of the Letter, one of the paper’s co-authors (DMK) initiated 
models and estimation procedures for a three-component model which includes the on- and 
off-binding to CBG and albumin, and hence estimation of free cortisol concentrations (2).  The 
original formulation of the approach occurred with the modeling of testosterone (T) and its 
binding to sex-hormone binding globulin (SHBG) and albumin (2).  One can imagine a hierarchy 
of potential data, accompanying LH and T, in this context.  This could consist of (a) simultaneous 
SHBG and albumin sampling at the same rate as LH and T (e.g., every 10 min for 24 hrs); (b) 
SHBG and albumin sampled less frequently, possibly only once (at the extreme); or, (c) SHBG 
and albumin are not observed, but rather populational assumptions are made so to achieve 
estimated fractions of free T, T-SHBG and T-albumin.  The original modeling was concerned 
with the data settings of (a)and (b), and less so that of (c) (3-5).    The modeling approach was 
then applied to the HPA axis (2, 6, 7). The approach involved the construction of values for the 
off- and on-rate constants for CBG and albumin binding, calculated from literature-based values 
for the population mean equilibrium association (M-1) and dissociation (M) constants for each 
of cortisol-CBG and cortisol-albumin, as well as mean binding capacities for CBG and albumin, 
and (in some cases) the half-lives for the off-rates for each of CBG and albumin.   
      The above modeling and resulting estimation methodology utilizing all three levels of 
cortisol dynamics in the blood, is certainly valid, especially in the data setting (a).  The issue 
though is the potential effect of the imposed assumptions on the estimation, as one proceeds 
from the context of (a), where the carrier proteins are sufficiently sampled, to that of (c) where 
they are not sampled, but are replaced by populational assumptions.  This is the setting of the 
present manuscript (1).  In the Critically Ill (CI) group, CBG and albumin were measured for each 
subject at the beginning and end of the 24-hr period.  The CI group’s CBG and albumin mean 
and SD values are given in Table 1 within the manuscript; the values are in the normal range. 
For the control group, neither CBG nor albumin were measured.   
          To have estimated free cortisol in the manuscript would have necessitated different 
estimation methods for the two groups.  One potentially could have first estimated free cortisol 
in both groups, not utilizing the CI group’s CBG and albumin values. Then, one could estimate 
free cortisol for the CI group, utilizing the carrier protein data.  If there was no difference 
between the two methods for the CI group, then free cortisol could have been estimated for 
both groups by the same method.  This was not done, mainly because of the following 
reasoning.  The perspective of the co-author (DMK) was that the imposition of assumptions on 
the unobserved on- and off-binding, with no carrier protein data, may well result in estimation 
bias.  It is not unlike an attempt to find a path of least action, where one may have wrongly 
imposed restrictions on the path passing through specified multiple points at certain times.   
        The alternative is (and was) a “lumping” of all the dynamical components into just two 
terms: fast- and slow-rates of elimination; one might further assume a fixed half-life for the fast 
rate.  That is, our conclusion in this context was that we would consider the carrier protein 
binding effect as being manifested in the other two rates, and to do the estimation as a two-
component model.  We fixed the fast rate half-life for cortisol at 2.41min and for ACTH at 
3.5min, which are published, population-based estimates.  Hence, it was then the slow rates 
which were estimated.  The fast rate dynamics should be reasonably similar for the two groups 
(this is mainly as a result of re-distribution of the molecules), and that physiological effects.   
Under these assumptions, with any carrier protein effects being subsumed within the estimates 
of the slow rate of elimination, one would expect accurate cortisol secretion rate estimates.  
We observed estimates for the slow rate half-life 53 vs 56 min for the CI and control groups 
respectively and statistically concluded that there was no difference.   In (6-7), CBG and albumin 
were not observed, and the approach taken was that of the present manuscript. 
     We did analyze the ACTH data, which is presented in Table 3 in the manuscript.   Because of 
the restriction as to the volume of blood withdrawal in the CI group, ACTH was assayed every 
hour, not every 10 min.  The control group ACTH was assayed every 10 min, and comparisons 
were done on the control group to see the effects of subsampling ACTH every hour vs every 10 
min, for both the estimation of ACTH secretion as well as the estimation of the ACTH-cortisol 
dose response parameters.   Those results are included in the supplementary data.  The 
estimation of the efficacy (parameter) of the ACTH drive on cortisol secretion rate, only involves 
interpolation in the sense that the ACTH feedforward signal had to be interpolated at the 10 
min level, in the case of the CI group.  The logistic dose-response function that was utilized was 
the symmetric logistic and we did not extend the ACTH-cortisol curve in any manner. 
       As to what effect the potential measurement of CBG and albumin, and the inclusion of a 
third-component for cortisol could have had on our estimates of cortisol secretion and its 
modulation by ACTH, it is difficult to infer.  For example, in this context, with the limitations on 
the amounts of blood that can be withdrawn, one can only assume that any changes in CBG 
amounts in the critically ill, would be manifested in the slow rate estimates, i.e., the 
composition.  Further, the specific critical illness being studied, could or could not respond 
differently to variations in CBG and albumin.  Hence, in response to the primary question in the 
Letter to the Editor, it is difficult to infer the potential consequences that CBG and albumin 
could have had on the estimates of the cortisol secretion rate and its modulation via ACTH, and 
the comparison of the present manuscript to that of other critical illnesses.   
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